Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 24 | 2025 | 2183 | 3.210 |
Why?
|
Botswana | 37 | 2025 | 1062 | 2.400 |
Why?
|
Heterocyclic Compounds, 3-Ring | 9 | 2024 | 296 | 2.380 |
Why?
|
HIV Infections | 43 | 2025 | 17589 | 2.100 |
Why?
|
Anti-Retroviral Agents | 13 | 2024 | 1794 | 2.060 |
Why?
|
Infectious Disease Transmission, Vertical | 12 | 2023 | 1360 | 2.000 |
Why?
|
Pregnancy Outcome | 20 | 2025 | 2957 | 1.780 |
Why?
|
Premature Birth | 17 | 2025 | 1814 | 1.710 |
Why?
|
Neural Tube Defects | 3 | 2019 | 255 | 1.640 |
Why?
|
Benzoxazines | 4 | 2020 | 321 | 1.170 |
Why?
|
Oxazines | 9 | 2024 | 358 | 1.150 |
Why?
|
HIV Seropositivity | 3 | 2023 | 967 | 0.990 |
Why?
|
Pregnancy | 50 | 2025 | 30175 | 0.900 |
Why?
|
Pyridones | 8 | 2024 | 819 | 0.790 |
Why?
|
Abnormalities, Drug-Induced | 3 | 2024 | 337 | 0.780 |
Why?
|
Infant Mortality | 3 | 2016 | 751 | 0.780 |
Why?
|
Maternal-Fetal Relations | 1 | 2021 | 25 | 0.780 |
Why?
|
Stillbirth | 12 | 2024 | 376 | 0.770 |
Why?
|
Anti-HIV Agents | 10 | 2024 | 4576 | 0.760 |
Why?
|
Placentation | 1 | 2021 | 78 | 0.750 |
Why?
|
HIV Integrase Inhibitors | 2 | 2019 | 165 | 0.670 |
Why?
|
Piperazines | 9 | 2024 | 2553 | 0.570 |
Why?
|
Diarrhea, Infantile | 1 | 2016 | 100 | 0.520 |
Why?
|
Congenital Abnormalities | 2 | 2024 | 703 | 0.500 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2021 | 1903 | 0.500 |
Why?
|
Breast Feeding | 3 | 2021 | 1364 | 0.480 |
Why?
|
Infant Formula | 1 | 2016 | 195 | 0.480 |
Why?
|
Postpartum Period | 2 | 2024 | 1198 | 0.470 |
Why?
|
Infant, Newborn | 25 | 2025 | 26394 | 0.470 |
Why?
|
Child Mortality | 1 | 2016 | 204 | 0.450 |
Why?
|
Alkynes | 4 | 2020 | 327 | 0.450 |
Why?
|
Cyclopropanes | 4 | 2020 | 437 | 0.430 |
Why?
|
Respiratory System | 1 | 2016 | 565 | 0.420 |
Why?
|
Gestational Age | 2 | 2019 | 3610 | 0.410 |
Why?
|
Pregnancy Complications | 6 | 2023 | 2965 | 0.400 |
Why?
|
Drug Therapy, Combination | 5 | 2019 | 6320 | 0.370 |
Why?
|
Zidovudine | 3 | 2017 | 625 | 0.360 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2023 | 523 | 0.350 |
Why?
|
Mothers | 3 | 2020 | 2211 | 0.350 |
Why?
|
Female | 56 | 2025 | 397464 | 0.300 |
Why?
|
Pregnant Women | 5 | 2024 | 571 | 0.290 |
Why?
|
HIV-1 | 6 | 2024 | 6963 | 0.270 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2013 | 862 | 0.270 |
Why?
|
Prenatal Care | 3 | 2024 | 1159 | 0.260 |
Why?
|
Pneumonia | 2 | 2019 | 2163 | 0.250 |
Why?
|
Infant | 16 | 2024 | 36541 | 0.240 |
Why?
|
Folic Acid | 4 | 2025 | 1336 | 0.240 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2541 | 0.240 |
Why?
|
Maternal Mortality | 2 | 2024 | 307 | 0.230 |
Why?
|
Antibodies, Neutralizing | 3 | 2024 | 2009 | 0.230 |
Why?
|
Hospital Mortality | 2 | 2019 | 5369 | 0.230 |
Why?
|
Anemia | 2 | 2025 | 1516 | 0.220 |
Why?
|
Iron | 4 | 2025 | 1813 | 0.210 |
Why?
|
Humans | 59 | 2025 | 768887 | 0.210 |
Why?
|
Dietary Supplements | 3 | 2025 | 3442 | 0.210 |
Why?
|
Prevalence | 7 | 2024 | 15875 | 0.210 |
Why?
|
Infant, Small for Gestational Age | 3 | 2021 | 467 | 0.190 |
Why?
|
Polydactyly | 1 | 2021 | 57 | 0.180 |
Why?
|
Adult | 29 | 2025 | 223818 | 0.180 |
Why?
|
HIV Antibodies | 2 | 2024 | 1341 | 0.170 |
Why?
|
HIV Protease Inhibitors | 1 | 2022 | 432 | 0.170 |
Why?
|
Pregnancy Trimester, First | 1 | 2024 | 917 | 0.170 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 135 | 0.170 |
Why?
|
Quarantine | 1 | 2020 | 186 | 0.150 |
Why?
|
Obstetric Labor, Premature | 1 | 2020 | 266 | 0.150 |
Why?
|
Hospitals, District | 1 | 2019 | 114 | 0.150 |
Why?
|
Lymphopenia | 1 | 2020 | 299 | 0.150 |
Why?
|
HIV | 5 | 2022 | 1596 | 0.140 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2020 | 622 | 0.140 |
Why?
|
Africa | 1 | 2019 | 726 | 0.140 |
Why?
|
Syphilis | 1 | 2019 | 243 | 0.140 |
Why?
|
Fetal Death | 1 | 2018 | 434 | 0.130 |
Why?
|
Cervix Uteri | 1 | 2020 | 576 | 0.130 |
Why?
|
Antimalarials | 1 | 2022 | 908 | 0.130 |
Why?
|
Virus Diseases | 1 | 2021 | 724 | 0.130 |
Why?
|
Young Adult | 14 | 2025 | 60110 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1560 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2023 | 1162 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2129 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1251 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 868 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 3143 | 0.110 |
Why?
|
Travel | 1 | 2019 | 805 | 0.110 |
Why?
|
Causality | 1 | 2019 | 1255 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2871 | 0.110 |
Why?
|
Malaria | 1 | 2022 | 1241 | 0.100 |
Why?
|
Shock, Septic | 1 | 2019 | 774 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2022 | 3069 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 843 | 0.100 |
Why?
|
Population Surveillance | 2 | 2019 | 2597 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1882 | 0.100 |
Why?
|
Child | 5 | 2023 | 80969 | 0.090 |
Why?
|
Micronutrients | 2 | 2025 | 390 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12563 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4862 | 0.090 |
Why?
|
Alanine | 2 | 2024 | 614 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4053 | 0.080 |
Why?
|
Feces | 1 | 2016 | 1511 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3216 | 0.080 |
Why?
|
Prospective Studies | 5 | 2020 | 54950 | 0.080 |
Why?
|
Medication Adherence | 2 | 2018 | 2192 | 0.080 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5520 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2013 | 2931 | 0.070 |
Why?
|
Risk Assessment | 3 | 2018 | 24330 | 0.070 |
Why?
|
Cause of Death | 2 | 2019 | 3721 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7472 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7860 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2219 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3908 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10845 | 0.060 |
Why?
|
Risk Factors | 5 | 2023 | 74971 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4711 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10115 | 0.060 |
Why?
|
Viral Load | 2 | 2024 | 3398 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10397 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22294 | 0.050 |
Why?
|
Clinical Competence | 1 | 2019 | 4859 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Fertilization | 1 | 2023 | 197 | 0.050 |
Why?
|
Compassionate Use Trials | 1 | 2021 | 50 | 0.050 |
Why?
|
Chloroquine | 1 | 2022 | 275 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2021 | 83 | 0.050 |
Why?
|
E-Selectin | 1 | 2023 | 578 | 0.040 |
Why?
|
Teratogens | 1 | 2021 | 119 | 0.040 |
Why?
|
Ritonavir | 1 | 2022 | 332 | 0.040 |
Why?
|
Male | 10 | 2024 | 365249 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2023 | 692 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 232 | 0.040 |
Why?
|
Toes | 1 | 2021 | 209 | 0.040 |
Why?
|
Vitamin B 6 | 1 | 2021 | 237 | 0.040 |
Why?
|
Cervical Length Measurement | 1 | 2020 | 46 | 0.040 |
Why?
|
Clinical Audit | 1 | 2019 | 29 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1133 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 725 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 389 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2019 | 62 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2021 | 585 | 0.040 |
Why?
|
Adenine | 1 | 2024 | 995 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 600 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2598 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2021 | 528 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.040 |
Why?
|
Fingers | 1 | 2021 | 512 | 0.040 |
Why?
|
Selection Bias | 1 | 2019 | 360 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1668 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2021 | 925 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 735 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41800 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2742 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2021 | 12469 | 0.030 |
Why?
|
Zinc | 1 | 2021 | 678 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2021 | 372 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2021 | 610 | 0.030 |
Why?
|
Tachycardia | 1 | 2019 | 599 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9264 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14795 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1757 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2019 | 409 | 0.030 |
Why?
|
Parturition | 1 | 2019 | 453 | 0.030 |
Why?
|
Labor, Induced | 1 | 2016 | 156 | 0.030 |
Why?
|
Adolescent | 4 | 2025 | 89247 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 587 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39394 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2108 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2088 | 0.030 |
Why?
|
Weight Gain | 1 | 2024 | 2359 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1721 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 42684 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 950 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2025 | 1886 | 0.030 |
Why?
|
Hypotension | 1 | 2019 | 888 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2017 | 618 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1818 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1076 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2026 | 0.020 |
Why?
|
United States | 3 | 2024 | 73180 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1241 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3858 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5150 | 0.020 |
Why?
|
Drug Utilization | 1 | 2015 | 1191 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4413 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2527 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 223740 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2720 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 81892 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23847 | 0.020 |
Why?
|
Public Health | 1 | 2018 | 2680 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7460 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26384 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8745 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15955 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59738 | 0.010 |
Why?
|
Animals | 1 | 2021 | 169408 | 0.010 |
Why?
|
Aged | 1 | 2019 | 171790 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_